(Q51008180)

26 March 2018

title

Effects of insulin and amyloid β(1-42) oligomers on glucose incorporation and mitochondrial function in cultured rat hippocampal neurons. (English)

1 reference

26 March 2018

author name string

Yoshiaki Miichi

1

1 reference

26 March 2018

Takashi Sakurai

2

1 reference

26 March 2018

Taichi Akisaki

3

1 reference

26 March 2018

Koichi Yokono

4

1 reference

26 March 2018

publication date

18 May 2011

1 reference

26 March 2018

Geriatrics and Gerontology International

published in

1 reference

26 March 2018

volume

11

1 reference

26 March 2018

issue

4

1 reference

26 March 2018

page(s)

517-524

1 reference

26 March 2018

Pathways towards and away from Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Hippocampal hypometabolism predicts cognitive decline from normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid beta-peptide decreases neuronal glucose uptake despite causing increase in GLUT3 mRNA transcription and GLUT3 translocation to the plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Mitoenergetic failure in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Association of metabolic syndrome with Alzheimer disease: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

The epidemiology of adiposity and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

A nonradioisotope, enzymatic assay for 2-deoxyglucose uptake in L6 skeletal muscle cells cultured in a 96-well microplate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Synaptic adaptation to repeated hypoglycemia depends on the utilization of monocarboxylates in Guinea pig hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid-β neurotoxicity restricts glucose window for neuronal survival in rat hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Glucose transporter expression in the central nervous system: relationship to synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Different effects of monocarboxylates on neuronal survival and beta-amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid-β triggers the release of neuronal hexokinase 1 from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid oligomers: formation and toxicity of Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid-beta dynamics correlate with neurological status in the injured human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00712.X

10.1111/J.1447-0594.2011.00712.X

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

21592272

1 reference

26 March 2018